Concepedia

Nalini Singh

NS

Statistics

Publications

6

Citations

297

H-Index

6

Active since

1996

Affiliations

University College London(Current)

University of Cape Town

St. Jude Children's Research Hospital

Nalini Singh is an author at University College London specializing in pharmacology, oncology, and pharmacy.

Publications per year

1996–2018

6

Publications

6

High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen

Norbert Ndjeka, Kathryn Schnippel, Iqbal Master et al. · European Respiratory Journal · 2018 · 134 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk‐1) following lentiviral‐mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model

Chara Kyriakou, Kwee Yong, Reuben Benjamin et al. · The Journal of Gene Medicine · 2005 · 50 citations

Medicine, Cancer Biology, Oncology +14

POSITIVE CORRELATION BETWEEN APOPTOTIC AND PROLIFERATIVE INDICES IN GASTROINTESTINAL LYMPHOMAS OF MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT)

Ming‐Qing Du, Nalini Singh, AZIZ HUSSEUIN et al. · The Journal of Pathology · 1996 · 46 citations

Medicine, Oncology, Pathology +17

Continuous delivery of human type I interferons (α/β) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model

Reuben Benjamin, Asim Khwaja, Nalini Singh et al. · Blood · 2006 · 29 citations · Full text

Pharmacy, Oncology, Pharmacology +5

Molecular Docking for Prediction and Interpretation of Adverse Drug Reactions

Heng Luo, Achille Fokoue-Nkoutche, Nalini Singh et al. · Combinatorial Chemistry & High Throughput Screening · 2018 · 23 citations

Life Sciences, Bioinformatics, Pharmacology +17

1–5 of 6